From Medical Relief to Addiction Epidemic
Srinagar, 16 April 2025: A Silent Threat Emerges
Pregabalin and Tapentadol, two commonly prescribed painkillers, are at the center of a growing drug abuse crisis in India, particularly in regions like Kashmir. Initially intended for nerve pain and severe physical discomfort, these medications have quietly transformed into substances of addiction, wreaking havoc among the youth and vulnerable populations.
The Rise of Abuse
Pregabalin, often prescribed for neuropathic pain, and Tapentadol, an opioid-like painkiller, have become easily accessible due to their over-the-counter (OTC) availability. Users, often without prescriptions, refer to these drugs by slang terms like “Koda” and purchase them in bulk. The affordability of Pregabalin (₹10–₹20 per capsule) and Tapentadol has made them attractive options for those seeking a “harmless” high.
A study conducted at SMHS Hospital’s De-addiction Center in 2024 revealed that 16% of heroin users also abused Tapentadol, often to dull withdrawal symptoms. Pregabalin, meanwhile, is consumed in dangerously high doses, with users reporting daily intakes of up to 1200 mg for its euphoric effects.
Health Risks and Consequences
Experts warn that these medications, while legal, pose severe health risks when misused:
- Tapentadol: Causes dependence, overdose, and withdrawal symptoms similar to other opioids.
- Pregabalin: Leads to sedation, cognitive impairment, respiratory depression, seizures, and even death in high doses.
Dr. Yasi Rather, in charge of SMHS Hospital’s De-addiction Center, emphasized the gravity of the situation: “These drugs are catching the youth and can have serious consequences. Withdrawal and dependence are real even in these medications that many of our young generation people swear to be harmless”.
Regulatory Measures
The Central Drugs Standard Control Organisation (CDSCO) is considering stricter regulations to curb the misuse of these drugs. Pregabalin may soon be classified under Schedule H1, requiring a valid prescription for purchase, while Tapentadol could be categorized as a psychotropic substance under the Narcotic Drugs and Psychotropic Substances (NDPS) Act.
Looking Ahead
As the misuse of Pregabalin and Tapentadol continues to fuel addiction, the focus remains on implementing stricter controls, raising public awareness, and providing support for those battling dependency. The crisis serves as a stark reminder of the need for vigilance in the regulation and distribution of medications.
